SCHEMBL2347220

SCHEMBL2347220

CCCCCCOC(CO)COCC(O)CO

nearest known ligand 0.71

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.71
HTT P42858 1/20 0.50
ALDH1A1 P00352 1/20 0.49
CNR1 P21554 1/20 0.49
CNR2 P34972 1/20 0.49
LPAR1 Q92633 5/20 0.46
LPAR3 Q9UBY5 5/20 0.46
LPAR2 Q9HBW0 2/20 0.46
KDM4E B2RXH2 1/20 0.46
DUSP3 P51452 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
LMNA P02545 1/20 0.46
DNM1 Q05193 1/20 0.46
LPAR5 Q9H1C0 2/20 0.44
PLA2G2C Q5R387 1/20 0.43
LPAR6 P43657 1/20 0.43
LPAR4 Q99677 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2354120 1.00 USP2 (0.71) USP2HTTALDH1A1CNR1CNR2
SCHEMBL2345876 1.00 USP2 (0.71) USP2HTTALDH1A1CNR1CNR2
SCHEMBL3325348 1.00 USP2 (0.71) USP2HTTALDH1A1CNR1CNR2
SCHEMBL2840856 1.00 USP2 (0.71) USP2HTTALDH1A1CNR1CNR2
SCHEMBL2347679 0.98 USP2 (0.68) USP2HTTALDH1A1CNR1CNR2
SCHEMBL2348818 0.93 USP2 (0.59) USP2HTTALDH1A1CNR1CNR2
SCHEMBL9813387 0.92 USP2 (0.69) USP2HTTALDH1A1CNR1CNR2
SCHEMBL10420319 0.92 USP2 (0.80) USP2HTTLPAR1LPAR3LPAR2
SCHEMBL28686330 0.91 CNR1 (0.64) USP2ALDH1A1CNR1CNR2LPAR1
SCHEMBL9189445 0.91 CNR2 (0.56) USP2HTTALDH1A1CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120172631-A1 PHOSPHATIDYL OLIGOGLYCEROLS MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E. V. (DE) 2012-07-05 US disclosed
US-8076520-B2 Phosphatidyl oligoglycerols MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) 2011-12-13 US disclosed
US-8007545-B2 Deodorant compositions KAO CORPORATION (JP) 2011-08-30 US disclosed
US-20100280282-A1 PHOSPHATIDYL OLIGOGLYCEROLS MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) 2010-11-04 US disclosed
US-20070117739-A1 Deodorant compositions KAO CORPORATION 2007-05-24 US disclosed
EP-1787689-A1 Deodorant compositions Kao Corporation (JP) 2007-05-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100280282-A1 PHOSPHATIDYL OLIGOGLYCEROLS PHOSPHO1, SGMS2, LIPG USP2 2163/4885HTT 3647/4885ALDH1A1 3095/4885
US-20120172631-A1 PHOSPHATIDYL OLIGOGLYCEROLS PHOSPHO1, SGMS2, LIPG USP2 2163/4885HTT 3647/4885ALDH1A1 3095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.